TickerFactsScreenerDevelopers

Viking Therapeutics, Inc. (VKTX) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2014: $25.17M2015: $6.71M2016: $6.49M2017: $8.66M2018: $4.56M2019: $7.14M2020: $12.16M2021: $8.78M2022: $23.21M2023: $20.07M2024: $28.04M2025: $76.67M$76.67M
2014Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$76.67M+173.4%
2024$28.04M+39.7%
2023$20.07M-13.5%
2022$23.21M+164.4%
2021$8.78M-27.8%
2020$12.16M+70.4%
2019$7.14M+56.4%
2018$4.56M-47.3%
2017$8.66M+33.3%
2016$6.49M-3.3%
2015$6.71M-73.3%
2014$25.17M—